Step 1: Understanding the Question:
Vecuronium is a widely used non depolarising muscle relaxant, and this question asks for the statement about it that is wrong, not the one that is right.
Step 2: Key Formula or Approach:
One of vecuronium's main selling points over older agents like pancuronium is that it is largely free of unwanted heart and blood pressure effects. Keep this fact in mind while checking each option.
Step 3: Detailed Explanation:
Vecuronium is well known for cardiovascular stability. It does not meaningfully block the vagus nerve or release histamine at usual doses, so it does not raise the heart rate or drop the blood pressure the way pancuronium or older relaxants can. Saying it has a high incidence of cardiovascular side effects is the wrong statement, and this is the one we are looking for.
Vecuronium acts for a comparatively brief period compared with long acting relaxants such as pancuronium, so describing its block as short in duration fits its accepted profile and is a correct statement.
Vecuronium is mainly cleared through the liver and bile rather than through the kidney, so a single usual dose in a patient with kidney disease does not need adjustment. This is a correct statement, though repeated dosing can still build up over time.
Vecuronium is a lipid soluble, aminosteroid compound, and this lipophilic nature is exactly what lets it get taken up by the liver and excreted in bile. This is a correct statement.
Step 4: Final Answer:
The false statement is that vecuronium has a high incidence of cardiovascular side effects, so option 1 is the answer.